Gedeon Richter Romania News and Activities

Gedeon Richter Romania is owned by Gedeon Richter.

Gedeon Richter is a company listed under the stock ticker RGEDF (HU).

Gedeon Richter has a direct presence in 4 countries.

Gedeon Richter has 3 subsidiaries including Celmatix, Gedeon Richter Romania and Richter Helm BioLogics.

They are in:

• Biotechnology75%
• Pharmaceuticals25%

Acquisition, funding and merger involving Gedeon Richter.

• Gedeon Richter has acquired Celmatix (posted on May 8 2026).

View the org chart displaying its 8 main executives

Most searched biographies at Gedeon Richter Romania

• Dana Chelărescu, Director General
• Halkó Tímea, Board Member
• Szénási Attila, Member of the Supervisory Board

Create your alert
to follow the executive moves at Gedeon Richter Romania.

Gedeon Richter has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Gedeon Richter Romania

• Richter receives European Commission approval for Tuyory®, its biosimilar tocilizumab in multiple indications
• Richter receives European Commission approval for FYLREVY® (Estetrol tablet) as Hormonal Replacement Therapy for oestrogen deficiency symptoms in postmenopausal women
• Richter Acquires Discovery Portfolio of Celmatix
• Richter and Fuji Sign an Agreement for Joint Development Projects in Women’s Health
• Update on Phase II study of ABBV-932 (RGH-932) for the treatment of bipolar depression
• Richter and Fuji Strengthen Strategic Collaboration
• Richter Receives Positive CHMP Opinion for FYLREVY® (Estetrol tablet)
• Richter Extends Its Support to Africa – The First Year of the House of Hope in Bamako in Numbers
• Richter publishes Q3 results
• The European Commission approves Bio-Thera’s BAT2206 (USYMRO®, a biosimilar ustekinumab), to be commercialized by Richter in Europe
• View more press releases Close

Social media about Gedeon Richter Romania

• Gedeon Richter Romania on Wikipedia, Google News & Yahoo Finance
• Gedeon Richter Romania on LinkedIn, X (Twitter) & YouTube